Skip to main content
. Author manuscript; available in PMC: 2020 Aug 24.
Published in final edited form as: Stem Cells. 2010 Apr;28(4):649–660. doi: 10.1002/stem.324

Table 1.

Expression of putative tumor stem cell markers in the NCI60 tumor cell line panel. Expression levels of CD15/CD24/CD44 or expression levels of CD133 and ALDH activity were analyzed by FACS analysis (50,000 cells/sample), and the size of marker positive and marker negative populations was determined using FlowJo (Treestar Inc). For each marker, the size of the marker positive subpopulation was determined (percent positive cells), and data were centered to the mean. FACS analysis was performed in triplicate

Tumor Type Cell Line Name CD44+ CD24+ CD133+ CD15+ ALDH+ CD44+ CD24[minus] CFU (2-D) soft agar assay
hematopoeitic CCRF-CEM 8.44 0.53 0.04 7.59 0.03 8.29 6
hematopoeitic HL-60 43.01 0.03 0.07 56.77 0.04 42.98 32
hematopoeitic K-562 0.13 0.31 0.09 44.91 12.86 0.11 64
hematopoeitic MOLT-4 0.57 0.49 0.05 0.39 1.32 0.54 28
hematopoeitic RPMI-8226 0.09 0.19 0.05 1.68 0.00 0.06 18
hematopoeitic SR 0.08 0.22 0.07 0.21 0.00 0.06 12
NSC Lung A549/ATCC 84.41 71.73 3.64 2.05 2.55 17.84 94 63
NSC Lung EKVX 77.00 81.47 1.95 0.48 9.12 7.86 35 0
NSC Lung HOP-62 81.41 4.35 1.91 0.87 2.46 77.46 45 37
NSC Lung HOP-92 95.44 1.61 0.25 1.85 0.48 93.99 15
NSC Lung NCI-H226 89.32 16.41 0.15 0.90 14.76 74.05 20 0
NSC Lung NCI-H23 30.95 4.30 0.11 43.51 0.01 27.97 42 27
NSC Lung NCI-H322M 54.49 52.65 3.45 88.27 0.01 23.09 20 29
NSC Lung NCI-H460 67.44 27.81 0.38 50.55 1.61 49.94 161 55
NSC Lung NCI-H522 1.40 81.25 0.18 2.41 35.74 0.02 29 1
Colon COLO 205 60.97 58.36 5.78 75.50 0.04 18.39 43 77
Colon HCC-2998 3.19 5.35 0.60 54.26 0.04 1.95 8 56
Colon HCT-116 58.62 0.78 63.18 0.14 0.56 57.93 126 102
Colon HCT-15 14.14 22.41 0.17 49.74 0.03 7.44 120 63
Colon HT-29 71.39 55.45 74.51 52.78 38.80 20.99 112 71
Colon KM12 48.87 9.06 10.71 10.65 3.42 40.29 29 37
Colon SW-620 11.49 52.84 22.04 90.05 0.11 2.25 158 60
CNS SF-268 86.02 18.77 1.39 0.25 0.03 68.12 37 8
CNS SF-295 98.07 24.70 0.09 4.37 0.03 73.56 65 54
CNS SF-539 84.22 33.08 0.13 0.48 0.00 52.76 30 18
CNS SNB-19 65.79 20.00 0.50 1.06 0.01 47.64 90 75
CNS SNB-75 88.23 20.36 0.25 0.39 0.69 68.13 10 8
CNS U251 77.53 4.98 0.55 0.12 0.75 72.82 38 99
Melanoma LOX IMVI 67.54 2.11 0.48 22.45 2.59 65.84 2 50
Melanoma M14 95.03 2.80 0.45 0.11 2.27 92.27 74 92
Melanoma MALME-3M 97.37 0.19 0.30 0.19 6.56 97.20 29 13
Melanoma SK-MEL-2 71.24 0.60 1.92 0.19 1.36 70.79 14 8
Melanoma SK-MEL-28 90.39 1.29 21.25 0.30 9.12 89.18 18 36
Melanoma SK-MEL-5 83.09 3.71 1.74 0.50 0.00 79.89 29 37
Melanoma UACC-257 87.94 12.52 3.84 0.26 8.62 75.66 27 22
Melanoma UACC-62 67.28 4.24 0.21 0.58 0.15 63.35 34 19
Melanoma MDA-MB-435 76.91 0.77 0.40 0.95 6.62 76.24 117
Ovarian IGROV-1 66.38 78.70 6.81 19.77 9.86 2.29 10 1
Ovarian OVCAR-3 12.70 91.33 22.46 88.38 0.97 0.05 19 0
Ovarian OVCAR-4 77.81 11.98 1.77 0.35 0.65 44.55 22 0
Ovarian OVCAR-5 98.97 54.69 19.36 0.54 0.04 44.42 41 5
Ovarian OVCAR-8 89.94 94.43 0.09 93.32 0.00 2.61 118 84
Ovarian SK-OV-3 90.74 58.49 0.78 8.16 0.00 34 19
Ovarian NCI/ADR-RES 73.62 64.05 0.54 84.19 0.96 19.67 19
Renal 786-0 94.59 96.32 0.93 15.01 2.58 0.99 37 2
Renal A-498 77.86 43.71 0.39 7.03 5.08 37.07 20 0
Renal ACHN 77.55 81.56 0.45 0.44 16.48 1.16 68 1
Renal CAKI-1 78.71 67.50 0.23 3.16 13.16 20.40 39 0
Renal RXF-393 93.59 63.98 0.20 5.34 0.00 30.26 3 1
Renal SN12C 14.63 93.43 57.47 41.57 0.00 0.04 17 34
Renal TK-10 94.31 91.45 0.75 91.84 1.66 6.25 53 4
Renal UO-31 89.70 21.47 5.93 4.98 0.02 68.74 28 0
Prostate PC-3 74.93 14.00 0.78 45.00 22.32 62.61 26
Prostate DU145 66.56 38.92 0.87 68.37 0.08 34.27 53
Breast MCF7 1.37 20.44 1.24 33.66 0.40 0.11 74
Breast MDA MB 231/ATCC 90.19 4.22 0.38 27.39 0.15 86.33 100
Breast Hs-578T 67.80 28.23 1.03 0.45 0.10 41.06 14
Breast BT-549 45.27 12.91 4.54 1.01 0.04 33.40 68
Breast T-47D 24.21 72.03 1.11 69.69 0.03 2.67 74